Ceftriaxone Sodium for Injection · DIN 02287633 · 1 g/Vial · powder for injection, vial
General benefit; Health Canada lists this DIN as Cancelled post market since 2025-07-30 — choose a marketed DIN from the same-category list.Discontinued July 30, 2025 · checked November 18, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2025-07-30 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2025-07-30 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Ceftriaxone Sodium for Injection · DIN 02287633
Manufacturer: Teva Canada Limited; listing date 2008-03-25
Health Canada: Cancelled post market since 2025-07-30 · brand CEFTRIAXONE SODIUM FOR INJECTION · ATC J01DD04 CEFTRIAXONE · form Powder for solution · route Intramuscular, Intravenous · ingredients CEFTRIAXONE (CEFTRIAXONE SODIUM) 1 G/VIAL · company Teva canada limited · schedule Prescription
Ceftriaxone Sodium for Injection: Formulary list price $12.50 per unit (the source does not state the unit; exact figure $12.4950). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02287633)
Source record
The source extract's flag for this DIN is unclear — confirm on the e-Formulary before prescribing (DIN 02287633).
DIN 02287633: Ceftriaxone Sodium for Injection
Raw flags: dinStatus=E, sec3=Y
Item: 081228045; group id 41; item number 0088; lccId None; manufacturer id TEV
Source form: Inj Pd-Vial Pk; strength: 1g/Vial
Recorded listing: General benefit; DIN status E, meaning unconfirmed
Source prices (unrounded): $12.4950; ministry $12.4950
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02287633
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77304
Interchangeable products
Ceftriaxone · DIN 02292270 · $12.4950
Ceftriaxone Sodium For Injection BP · DIN 02325616 · $12.4950
Ceftriaxone for Injection · DIN 02289695 · $12.4950
Ceftriaxone for Injection USP · DIN 02292874 · $12.4950
Rocephin · DIN 00657417 · not recorded
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since July 30, 2025 — choose a marketed DIN from the same-category list.